title: Efficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromes.
authors: Vasilia
authors: V
authors: Garypidou
authors: Evgenia
authors: E
authors: Verrou
authors: Sofia
authors: S
authors: Vakalopoulou
authors: Vasilios
authors: V
authors: Perifanis
authors: Konstantinos
authors: K
authors: Tziomalos
authors: Ioannis
authors: I
authors: Venizelos
mesh_terms: D000368:Aged; D004334:Drug Administration Schedule; D004921:Erythropoietin / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D011994:Recombinant Proteins; D016896:Treatment Outcome
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin